ProShares Ultra Semiconductors vs Health Care Select Sector SPDR Fund — how do they compare? ProShares Ultra Semiconductors trades at $90.41, while Health Care Select Sector SPDR Fund trades at $160.2. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, ProShares Ultra Semiconductors nearer its low. Which is the better fit depends on your goals.
| USD | XLV | |
|---|---|---|
Sector | Leveraged / Inverse | — |
52-Week High | $113.53 | $164.48 |
52-Week Low | $39.58 | $129.01 |
Signals from Pluang's Aura AI — not financial advice
USD trades at $83.24, up 1.19% with bearish technical signals from moving averages. Key support lies at $80 with resistance at $85. The company announced a $0.14 dividend for H1-2026, payable June 30, 2026. Recent news highlights include coverage of semiconductor sector volatility and earnings from various firms, though specific financials for USD are not detailed in the provided data.
The outlook remains cautious due to bearish technical indicators and limited fundamental data. Investment opportunity hinges on upcoming financial disclosures and sector performance, while risks include market volatility and reliance on broader economic conditions affecting semiconductor and related industries.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
USD is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Semiconductors™ Index. It is a tactical instrument designed for sophisticated traders looking to magnify short-term bullish views on the U.S. semiconductor industry, specifically focusing on large-cap leaders in the chip and equipment space.
Read more on USD →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →